ACI - 8th Annual Paragraph IV Disputes
April 28-29, 2014
New York, NY
In the eight years since its inception, American Conference Institute’s (ACI’s) Paragraph IV Disputes conference has become the pharmaceutical industry’s leading forum on Hatch-Waxman litigation. Each spring, the “who’s who” of Hatch-Waxman litigators and industry decision makers, as well as members of the judiciary and key government representatives gather in New York City at this forum to assess the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent end game and the pursuit of related profits. This “must-attend” event serves the legal and business needs of both branded and generic drug makers by providing invaluable “take aways” for legal strategies and cost-analysis for every facet of this complex litigation from pre-suit considerations to case filings through final adjudication.
Mark Jansen is the Moderator of a panel entitled, "Of Prior Art and Double Patenting: Exploring the Dichotomy Between the Federal Circuit and PTO on Obvious Findings and the Potential Impact of the Goodlatte Bill on Double-Patenting Type Obviousness
." Jim Stronski is one of the speakers on the topic, "A Pros and Cons Analysis of Launching At Risk and Survey of New Developments in Seeking Injunctive Relief and Damages
Crowell & Moring is one of the sponsors.
Crowell & Moring Participant(s):
For more information, please visit these areas: